Lewy Body Dementia, Parkinson’s & Alzheimer’s: Similarities and Differences
Wednesday, March 13th at 6pm via Zoom. Click HERE to Register!
Open Mobile Menu
Lewy Body Dementia, Parkinson’s & Alzheimer’s: Similarities and Differences
Wednesday, March 13th at 6pm via Zoom. Click HERE to Register!
Open Mobile Menu

Lewy Body Dementia, Parkinson's & Alzheimer's: Similarities and Differences

13mar6:00 pm7:15 pmLewy Body Dementia, Parkinson's & Alzheimer's: Similarities and DifferencesWhat You Need to Know from a Clinical & Caregiver Perspective

Event Details


If your loved one has been diagnosed with dementia, then a decline in memory or change in thinking is making it difficult to go about daily life. Although memory loss and altered thought are common to all dementias, there are different types, each with distinct causes and characteristics.

Join us to learn about the similarities and differences between Lewy-Body Dementia, Alzheimer’s & Parkinson’s. Learn what you can do to best support them as they cope with these challenges. Get caught up on the latest treatments available, including the new drug Leqembi®, which was approved by the FDA in June of last year to help treat the early stages of Alzheimer’s. And build a supportive network by connecting with fellow attendees and sharing personal experiences.

Keith N. Fargo, PhD, is the Director of Scientific Initiatives at the Lewy Body Dementia Association. Dr. Fargo earned his PhD in Neuroscience from Indiana University, where his research focused on the effects of hormones on the structure and function of spinal cord neurons that control movement. In his current role at the Lewy Body Dementia Association, he is responsible for the research activities of the LBDA, including the flagship LBDA Research Centers of Excellence, a network of 20 of the nation’s leading academic medical institutions focused on advancing our understanding of the disease, improving care, and carrying out clinical trials for Lewy body dementias.

Julia Wood, MOT, OTR/L is an occupational therapist who specializes in the treatment of individuals with Parkinson’s Disease and neurological movement disorders. She is the Director of Professional and Community Education for the Lewy Body Dementia Association and contracts with the University of Pennsylvania’s Parkinson’s Disease and Movement Disorders Center of Excellence to develop community engagement programming.

Donna Sperlakis is the Senior Director of Community Engagement at the Parkinson’s Foundation.  In this role, Donna is responsible for overseeing the development and delivery of community education programs and outreach initiatives.  Since joining the Parkinson’s Foundation, Donna has led the development of comprehensive in person and virtual community education programs with a focus on quality and consistency Prior to joining the Foundation, she spent ten years at a community hospital outside Chicago where in addition to managing the hospital’s volunteer services department, she developed and managed a successful Parkinson’s disease education and support program.

Claire Day, Chief Program Officer at the Alzheimer’s Association, has been on staff at the Alzheimer’s Association since 2001. She is the Chief Program Officer at the Northern California & Northern Nevada Chapter and as such, oversees all care and support operations and research initiatives. Claire Day is a clinical social worker and received her degree from Bloomsburg University of Pennsylvania. She has more than twenty years of experience as a family and professional educator in dementia care and has authored two forwards to Alzheimer’s caregiver books.

In partnership with:

For questions, please email Brooke Ballenger, Director of Community Partnerships, at bballenger@kensingotnsl.com.


(Wednesday) 6:00 pm - 7:15 pm EST


via ZOOM


Brooke Ballenger


Learn More